Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: A microarray search for effects of thyrotropin and iodide on angiogenesis factors

Thyroid

Volumn 16, Issue 6, 2006, Pages 545-554

  Yamada, Emiko ^a   Yamazaki, Kazuko ^a   Takano, Kazue ^b   Obara, Takao ^b   Sato, Kanji ^b  

^a Kanaji Hospital   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; IODIDE; PEROXIDASE; PLACENTAL GROWTH FACTOR; SODIUM IODIDE SYMPORTER; THYROGLOBULIN; THYROTROPIN; UROKINASE; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C;

ANGIOGENESIS; ARTICLE; BLEEDING; CONTROLLED STUDY; DNA MICROARRAY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHYROIDISM; NORTHERN BLOTTING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THYROID FOLLICLE; THYROID SURGERY;

BLOTTING, NORTHERN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GRAVES DISEASE; HUMANS; IODIDES; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY PROTEINS; THYROID GLAND; THYROTROPIN; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B;

EID: 33745982267     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.545     Document Type: Article

References (45)

1. Wolff J 1989 Excess iodide inhibits the thyroid by multiple mechanisms. Adv Exp Med Bio 261:211-244.
2. Marigold JH, Morgan AK, Earle DJ, Young AE, Croft DN 1985 Lugol's iodine: Its effect on thyroid blood flow in patients with thyrotoxicosis. Br J Surg 72-45-47.
3. Chang DC, Wheeler MH, Woodcock JP, Curley I, Lazarus JR, Fung H, John R, Hall R, McGregor AM 1987 The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism. Surgery. 102:1055-1061.
4. Patwardhan NA, Moront M, Rao S, Rossi S, Braverman LE 1993 Surgery still has a role in Graves' hyperthyroidism. Surgery 114:1108-1112.
5. Turner HE, Harris AL, Melmed S, Wass JA 2003 Angiogenesis in endocrine tumors. Endocr Rev 24:600-632.
6. Arntzenius AB, Smit LJ, Schipper J, van der Heide D, Meinders AE 1991 Inverse relation between iodine intake and thyroid blood flow: Color Doppler flow imaging in euthyroid humans. J Clin Endocrinol Metab 73:1051-1055.
7. th ed. J.B. Lippincott Co., Philadelphia, pp. 607-617.
8. Kriss JP 1970 Radioiotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab 31:315-323.
9. Ferrara N 2005 The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 94:209-231.
10. Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, Yamaguchi S, Shibuya M 1995 Stimulation of thyroid stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and fit mRNA expression in the rat thyroid in vivo. J Clin Invest 96:1295-1302.
11. 125I incorporation and de novo-synthesized thyroid hormone release in human thyroid follicles. J Clin Endocrinol Metab 80:473-479.
12. Nakajima K, Yamazaki K, Yamada E, Kanaji Y, Kosaka S, Sato K, Takano K 2001 Amiodarone stimulates interleukin-6 production in cultured human thyrocytes, exerting cytotoxic effects on thyroid follicles in suspension culture. Thyroid 11:101-109.
13. Ramsden JD 2000 Angiogenesis in the thyroid gland. J Endocrinol 166:475-480.
14. Sato K 2001 Vascular endothelial growth factors and thyroid diseases: Review Endocrine J 48:635-646.
15. International Human Genome Sequencing Consortium 2001 Initial sequencing and analysis of the human genome. Nature 409:861-921.
16. 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-α and interferon-γ in human thyrocytes in suspension culture. J Clin Endocrinol Metab 70:1735-1743.
17. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N 2003 The Sodium/Iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48-77.
18. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the selenodeiodinases. Endocr Rev 23:38-89.
19. Salvatore D, Tu H, Harney JW, Larsen PR 1996 Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 98:962-968.
20. Murakami M, Araki O, Hosoi Y, Kamiya Y, Morimura T, Ogiwara T, Mizuma H, Mori M 2001 Expression and regulation of type II iodothyronine deiodinase in human thyroid gland. Endocrinology 142:2961-2967.
21. Viglietto G, Romano A, Manzo G, Chiappetta G, Paoletti I, Califano D, Galati MG, Mauriello V, Bruni P, Lago CT, Fusco A, Persico MG 1997 Upregulation of the angiogenic factors P1GF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracilfed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization. Oncogene 15:2687-2698.
22. LeCouter J, Lin R, Ferrara N 2002 Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis. Nat Med 8:913-917.
23. Thompson SD, Franklyn JA, Watkinson JC, Verhaeg JM, Sheppard MC, Eggo MC 1998 Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia. J Clin Endocrinol Metab 83:1336-1341
24. Cocks HC, Thompson S, Turner FE, Logan A, Franklyn JA, Watkinson JC, Eggo MC 2003 Role and regulation of the fibroblast growth factor axis in human thyroid follicular cells. Am J Physiol Endocrinol Metab. 285:E460-469.
25. Ramsden JD, Cocks HC, Shams M, Nijjar S, Watkinson JC, Sheppard MC, Ahmed A, Eggo MC 2001 Tie-2 is expressed on thyroid follicular cells, is ncreased in goiter, and is regulated by thyrotropin through cyclic adenosine 3′,5′-monophosphate. J Clin Endocrinol Metab 86:2709-2716.
26. Ramsden JD, Yarram S, Mathews E, Watkinson JC, Eggo MC 2002 Thyroid follicular cells secrete plasminogen activators and can form angiostatin from plasminogen. J Endocrinol 173:475-481.
27. Yamazaki Y, Yamada E, Kanaji Y, Yanagisawa T, Kato Y, Takano K, Obara T, Sato K 2003 Genes Regulated by TSH and iodide in cultured human thyroid follicles: Analysis by cDNA microarray. Thyroid 13:149-158.
28. Yamazaki K, Yamada E, Kanaji Y, Yanagisawa T, Kato Y, Sato K, Takano K, Sakasegawa Y, Kaneko K 2003 Stimulation of cellular prion protein (PrPc) expression by TSH in human thyroid follicles. Biochem Biophys Res Commun 305:1034-1039.
29. Yuasa R, Eggo MC, Meinkoth J, Dillmann WH, Burrow GN 1992 Iodide induces transforming growth factor beta 1 (TGF-beta 1) mRNA in sheep thyroid cells. Thyroid 2:141-145.
30. Gartner R, Schopohl D, Schaefer S, Dugrillon A, Erdmann A, Toda S, Bechrner G 1997 Regulation of transforming growth factor beta 1 messenger ribonucleic acid expression in porcine thyroid follicles in vitro by growth factors, iodine, or delta-iodolactone. Thyroid 7:633-640.
31. Patel VA, Logan A, Watkinson JC, Uz-Zaman S, Sheppard MC, Ramsden JD, Eggo MC 2003 Isolation and characterization of human thyroid endothelial cells. Am J Physiol Endocrinol Metab 284:E168-176.
32. Hoffmann S, Hofbauer LC, Scharrenbach V, Wunderlich A, Hassan I, Lingelbach S, Zielke A 2003 Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors. J Clin Endocrinol Metab 89:6139-6145.
33. Ferrara N, Houck K, Jakeman L, Leung DW 1992 Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32.
34. Suzuki K, Mori A, Saito J, Moriyama E, Ullianich L, Kohn LD 1999 Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene. Endocrinology 140:5422-5430.
35. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. 2001 Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575-583.
36. Hung CJ, Ginzinger DG, Zarnegar R, Kanauchi H, Wong MG, Kebebew E, Clark OH, Duh QY 2003 Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. J Clin Endocrinol Metab 88:3694-3699
37. Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K 1998 Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273:8413-8418.
38. Enholm B, Paavonen K, Ristimaki A, Kumar V, Gunji Y, Klefstrom J, Kivinen L, Laiho M, Olofsson B, Joukov V, Eriksson U, Alitalo K 1997 Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14:2475-2483.
39. Blobe GC, Schiemann WP, Lodish HF 2000 Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358.
40. Wahl ML, Moser TL, Pizzo SV. 2004 Angiostatin and antiangiogenic therapy in human disease. Recent Prog Horm Res 59:73-104.
41. Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, Enghild J, Kwaan HC, Lee F, Kramer RA, Volpert O, Bouck N, Soff GA T 1997 The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci USA 94:10868-10872
42. Sato K, Miyakawa M, Onoda N, Demura H, Yamashita T, Miura M, Kasajima T, Yamazaki K, Obara T 1997 Increased concentration of vascular endothelial growth factor/vascular permeability factor in cyst fluid of enlarging and recurrent thyroid nodules. J Clin Endocrinol Metab 82:1968-1973.
43. Roberts WG, Palade GE 1995 Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor J Cell Sci 108:2369-2379.
44. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela C, Kalkkinen N, Alitalo K 1997 Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898-3911.
45. Lal G, Ituarte P, Kebebew E, Siperstein A, Duh QY, Clark OH. 2005 Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease? Thyroid 15:569-574.